BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu L, Zhang J, Zhang X, Cheng P, Liu L, Huang Q, Liu H, Ren S, Wei P, Wang C, Dou C, Chen L, Liu X, Zhang H, Chen M. HMGB1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target. J Mol Med (Berl) 2021;99:107-18. [PMID: 33128580 DOI: 10.1007/s00109-020-01998-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Teo Hansen Selnø A, Schlichtner S, Yasinska IM, Sakhnevych SS, Fiedler W, Wellbrock J, Berger SM, Klenova E, Gibbs BF, Fasler-Kan E, Sumbayev VV. High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells. Front Immunol 2021;12:675731. [PMID: 34234778 DOI: 10.3389/fimmu.2021.675731] [Reference Citation Analysis]
2 Jia S, He D, Liang X, Cheng P, Liu J, Chen M, Wang C, Zhang H, Meng C. Corilagin induces apoptosis and inhibits autophagy of HL‑60 cells by regulating miR‑451/HMGB1 axis. Mol Med Rep 2022;25:34. [PMID: 34850958 DOI: 10.3892/mmr.2021.12550] [Reference Citation Analysis]
3 Li C, Wang M, Shi Y, Xin H. SOSTDC1 acts as a tumor inhibitor in acute myeloid leukemia by downregulating the Wnt/β-catenin pathway. Environ Toxicol 2022. [PMID: 35442555 DOI: 10.1002/tox.23540] [Reference Citation Analysis]
4 Tu K, Yu Y, Wang Y, Yang T, Hu Q, Qin X, Tu J, Yang C, Kong L, Zhang Z. Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade. ACS Appl Mater Interfaces 2021;13:39003-17. [PMID: 34433253 DOI: 10.1021/acsami.1c08290] [Reference Citation Analysis]
5 Bruserud Ø, Reikvam H, Brenner AK. Toll-like Receptor 4, Osteoblasts and Leukemogenesis; the Lesson from Acute Myeloid Leukemia. Molecules 2022;27:735. [PMID: 35163998 DOI: 10.3390/molecules27030735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kong Q, Wei D, Xie P, Wang B, Yu K, Kang X, Wang Y. Photothermal Therapy via NIR II Light Irradiation Enhances DNA Damage and Endoplasmic Reticulum Stress for Efficient Chemotherapy. Front Pharmacol 2021;12:670207. [PMID: 33995101 DOI: 10.3389/fphar.2021.670207] [Reference Citation Analysis]
7 Huselton E, Rettig MP, Campbell K, Cashen AF, DiPersio JF, Gao F, Jacoby MA, Pusic I, Romee R, Schroeder MA, Uy GL, Marcus S, Westervelt P. Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS. Leuk Res 2021;110:106713. [PMID: 34619434 DOI: 10.1016/j.leukres.2021.106713] [Reference Citation Analysis]